The effect of pentoxifylline on the healing of full-thickness skin defects of diabetic and normal rats

European Journal of Plastic Surgery

Volumn 25, Issue 5, 2002, Pages 253-257

  Karasoy, A ^a,b   Kuran, I ^b   Turan, T ^b   Hacikerim, S ^b   Bas L ^b   Sungun, A ^b  

^a Şişli Etfal Teaching and Research Hospital ^*  (Turkey)

^b SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Diabetes; Pentoxifylline; Wound healing

Indexed keywords

PENTOXIFYLLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; EPITHELIZATION; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; SCAR; SKIN DEFECT; TENSILE STRENGTH; WOUND; WOUND HEALING;

EID: 20644457902     PISSN: 0930343X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00238-001-0341-9     Document Type: Article

References (29)

1. Adler PF (1991) Assessing the effects of pentoxifylline (Trental) on diabetic neurotrophic foot ulcers. J Foot Ankle Surg 30:300-303
2. Aker JS, Mancoll J, Lewis B, Colen LB (1997) The effects of pentoxifylline on random pattern skin-flap necrosis induced by nicotine treatment in the rat. Plast Reconstr Surg 100:66-71
3. Andreassen TT, Oxlund H (1987) The influence of experimental diabetes and insulin treatments on the biochemical properties of rat skin incisional wounds. Acta Chir Scand 153:405-409
4. Berman B, Duncan MR (1989) Pentoxifylline inhibits normal human dermal fibroblast in vitro proliferation, collagen, glycosaminoglycan, and fibronectin production, and increases collagenase activity. J Invest Dermatol 92:605-610
5. Bridges JM, Dalby AM, Millar JH, et al (1965) An effect of D-glucose on platelet stickiness. Lancet 1:75
6. Cross SE, Naylor IL, Coleman RA, Teo TC (1995) An experimental model to investigate the dynamics of wound contraction. Br J Plast Surg 48:189-197
7. Ferrari E, Fioravanti M, Patti AL, Viola C, Solerte SB (1987) Effects of long-term treatment (4 years) with pentoxifylline on haemorheological changes and vascular complications in diabetic patients. Pharmatherapeutica 5:26-29
8. Goldenberg S, Alex M, Josh R, Blumenthal H (1959) Nonatheromatous vascular disease of the lower extremity in diabetes mellitus. Diabetes 8:261
9. Goodson WH, Hunt TK (1977) Studies of wound healing in experimental diabetes. J Surg Res 22:221-227
10. Goodson W H, Hunt TK (1979) Wound healing and the diabetic patient. Surg Gynecol Obstet 149:600-608
11. Knox RD, Pratt MF, Adkins WY, Flick JT (1989) The use of pentoxifylline in a pig random skin-flap model. Laryngoscope 99:582
12. Le Gerfo FW, Coffman UD (1984) Vascular and microvascular disease of the foot in diabetes: implications for foot care. N Engl J Med 311:1615
13. Maeda N. Kon K, Imiazumi I, et al (1983) Alteration of rheological properties of human erythrocytes by crosslinking of membrane proteins. Biochim Biophys Acta 735:104
14. Mansford K, Opre L (1968) Comparison of metabolic abnormalities in diabetes mellitus induced by streptozotocin and by alloxan. Lancet 1:670
15. McMillan DE, Utterback NG, LaPuma J (1982) Reduced erythrocyte deformity in diabetes. Diabetes 31:64
16. Monteiro DT, Santamore WP, Nemir P (1986) The influence of pentoxifylline on skin-flap survival. Plast Reconstr Surg 77:277-281
17. Morain WD, Colen LB (1990) Wound healing in diabetes mellitus. Clin Plast Surg 17:493-501
18. Okumura M, Okuda T, Nakamura T, Yajima M (1996) Acceleration of wound healing in diabetic mice by bFGF. Biol Pharm Bull 19:530-535
19. Prakash A, Pandit PN, Sharma LK (1974) Studies of wound healing in diabetes. Int Surg 59:25-28
20. Roeren T, LeVeen R, Nugent L (1988) Photophlethysmographic documentation of improved microcirculation after pentoxifylline therapy. Angiology 39:929-933
21. Rosenthal S, Lerner B, DiBiase F, Enquist IF (1962) Relation of strength to composition in diabetic wounds. Surg Gynecol Obstet 115:437
22. Samlaska CP, Winfield EA (1994) Pentoxifylline. Clinical review. J Am Acad Dermatol 30:603-621
23. Schmid-Schonbein H, Wells R, Goldstone J (1969) Influence of deformability of human red cells upon blood viscosity. Circ Res 25:131
24. Simpson LO (1985) Intrinsic stiffening of red blood cell as the fundamental cause of diabetic nephropathy and microangiopathy: a new hypothesis. Nephron 39: 344-351
25. Sipperstein M, Unger R, Madison L (1968) Capillary basement membranes in normal subjects, diabetics and prediabetic patients J Clin Invest 47:1973
26. Stefanorich V (1975) The effects of pentoxifylline on erythrocyte adenine nucleotide levels in rats: IRCS Medical Science. Biochem Hematol Pharmacol 3:91
27. Takayanagi S, Ogawa Y (1980) Effects of pentoxifylline on skin-flap survival. Plast Reconstr Surg 65:763-767
28. Yessenow RS, Maves MD (1989) The effects of pentoxifylline on random skin-flap survival. Arch Otolaryngol Head Neck Surg 115:179
29. Yue DK, Swanson B, McLennan S, Marsh M, et al (1986) Abnormalities of granulation tissue and collagen formation in experimental diabetes, uremia and malnutrition. Diabet Med 3:221-225